Editorial: glioma subpopulations

Restricted access

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Information

Please include this information when citing this paper: published online November 5, 2010; DOI: 10.3171/2009.11.JNS091668.

© AANS, except where prohibited by US copyright law.

Headings

References

  • 1

    Galli RBinda EOrfanelli UCipelletti BGritti ADe Vitis S: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:701170212004

  • 2

    Griguer CEOliva CRGobin EMarcorelles PBenos DJLancaster JR Jr: CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3:e36552008

  • 3

    Hemmati HDNakano ILazareff JAMasterman-Smith MGeschwind DHBronner-Fraser M: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:15178151832003

  • 4

    Kesari SSchiff DHenson JWMuzikansky AGigas DCDoherty L: Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. Neuro Oncol 10:3003082008

  • 5

    Ma HIChiou SHHeung DYTai LKHuang PIKao CL: Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg [epub ahead of print November 5 2010; DOI: 10.3171/2009.11.JNS091396]

  • 6

    Ogden ATWaziri AELochhead RAFusco DLopez KEllis JA: Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 62:5055152008

  • 7

    Rosenblum MLGerosa MDougherty DVReese CBarger GRDavis RL: Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1:8858871982

  • 8

    Rosenblum MLGerosa MAWilson CBBarger GRPertuiset BFde Tribolet N: Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential. J Neurosurg 58:1701761983

  • 9

    Singh SKClarke IDHide TDirks PB: Cancer stem cells in nervous system tumors. Oncogene 23:726772732004

  • 10

    Singh SKClarke IDTerasaki MBonn VEHawkins CSquire J: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:582158282003

  • 1

    Bao SWu QMcLendon REHao YShi QHjelmeland AB: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:7567602006

  • 2

    Baumann FBjeljac MKollias SSBaumert BGBrandner SRousson V: Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme. J Neurooncol 67:1912002004

  • 3

    Griguer CEOliva CRGobin EMarcorelles PBenos DJLancaster JR Jr: CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3:e36552008

  • 4

    Joki THeese ONikas DCBello LZhang JKraeft SK: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:492649312000

  • 5

    Kang KBWang TTWoon CTCheah ESMoore XLZhu C: Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Int J Radiat Oncol Biol Phys 67:8888962007

  • 6

    Kang KBZhu CYong SKGao QWong MC: Enhanced sensitivity of celecoxib in human glioblastoma cells: induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy. Mol Cancer 8:662009

  • 7

    Kardosh ABlumenthal MWang WJChen TCSchönthal AH: Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther 3:55622004

  • 8

    Karim AMcCarthy KJawahar ASmith DWillis BNanda A: Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Anticancer Res 25:6756792005

  • 9

    Kesari SSchiff DHenson JWMuzikansky AGigas DCDoherty L: Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. Neuro Oncol 10:3003082008

  • 10

    Kuipers GKSlotman BJWedekind LEStoter TRBerg JSminia P: Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Int J Radiat Biol 83:6776852007

  • 11

    Nam DHPark KPark CIm YHKim MHLee S: Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Oncol Rep 11:2632682004

  • 12

    Petersen CPetersen SMilas LLang FFTofilon PJ: Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res 6:251325202000

  • 13

    Portnow JSuleman SGrossman SAEller SCarson K: A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. Neuro Oncol 4:22252002

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 60 60 8
Full Text Views 75 75 0
PDF Downloads 48 48 1
EPUB Downloads 0 0 0

PubMed

Google Scholar